Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 6/20 | 0.37 |
| ▸ | DRD2 | P14416 | 5/20 | 0.37 |
| ▸ | HTR2A | P28223 | 4/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | PREP | P48147 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | SMYD3 | Q9H7B4 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6211053 | 0.90 | CHRM4 (0.39) | CHRM4DRD4DRD2HTR2ADPP4 | |
| SCHEMBL6211570 | 0.89 | SLC6A5 (0.38) | CHRM4SMYD3LMNA | |
| SCHEMBL6210236 | 0.88 | CHRM4 (0.41) | CHRM4DRD4DRD2HTR2ADPP4 | |
| SCHEMBL6210587 | 0.88 | HDAC1 (0.42) | CHRM4DRD4DRD2HTR2ADPP4 | |
| SCHEMBL6208718 | 0.88 | LMNA (0.42) | CHRM4SMYD3LMNA | |
| SCHEMBL6209295 | 0.88 | CTSK (0.37) | HTR2AHDAC1SMYD3LMNAHDAC3 | |
| SCHEMBL6211038 | 0.88 | CTSK (0.41) | SMYD3LMNA | |
| SCHEMBL6209450 | 0.88 | CXCR3 (0.43) | CHRM4SMYD3LMNA | |
| SCHEMBL6209104 | 0.87 | CHRM4 (0.41) | CHRM4DRD4DRD2HTR2ADPP4 | |
| SCHEMBL6210230 | 0.87 | ROCK2 (0.40) | SMYD3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1546150-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | Amura Therapeutics Limited (GB) | 2005-06-29 | — | — | EP | claimed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | claimed |
| EP-1546150-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | Amura Therapeutics Limited (GB) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004007501-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | AMURA THERAPEUTICS LIMITED (GB) | 2004-01-22 | — | — | WO | disclosed |